Nexstim Plc

Helsinki Stock Exchange:NXTMH.HE

Sector

🤖 Technology

Industries

🔬 Clinical Trials

🖨 3D Printing

🚗 Autonomous Driving

🩺 Medical Instruments

🥽 Virtual Reality (VR)

Location

Finland

Market Cap

USD 103.37 M

Share Price

USD 13.86

Avg Daily Volume

6,299

Change (1 day)

-3.32%

Change (1 year)

355.48%

Change (YTD)

68.65%

Nexstim Plc Revenue for the year ending December 31, 2024: USD 9.05 M

Nexstim Plc Revenue is USD 9.05 M for the year ending December 31, 2024, a 13.09% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Nexstim Plc Revenue for the year ending December 31, 2023 was USD 8.00 M, a -21.53% change year over year.
Nexstim Plc Revenue for the year ending December 31, 2022 was USD 10.19 M, a 39.96% change year over year.
Nexstim Plc Revenue for the year ending December 31, 2021 was USD 7.28 M, a 44.91% change year over year.
Nexstim Plc Revenue for the year ending December 31, 2020 was USD 5.03 M, a 33.75% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

Helsinki Stock Exchange: NXTMH.HE

Nexstim Plc

CEO	Mr. Mikko Karvinen
IPO Date	Nov. 14, 2014
Location	Finland
Headquarters	ElimAeenkatu 9 B
Employees	40
Sector	🤖 Technology
Industries Clinical Trials 🖨 3D Printing 🚗 Autonomous Driving 🩺 Medical Instruments 🥽 Virtual Reality (VR)

Description

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.